DEFA14A: Others
DEFA14A: Others
DEF 14A: Definitive information statements
Jasper Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Jasper Therapeutics | 8-K: Current report
Jasper Therapeutics | 8-K: Current report
Jasper Therapeutics | 8-K: Current report
Jasper Therapeutics | 8-K: Current report
Jasper Therapeutics | 8-K: Current report
Jasper Therapeutics | DEF 14A: Definitive information statements
Jasper Therapeutics | PRE 14A: Preliminary proxy statements relating to merger or acquisition
Jasper Therapeutics | 8-K: Jasper Therapeutics Reports Third Quarter 2023 Financial Results and Provides Business Update
Jasper Therapeutics | 8-K: Current report
Jasper Therapeutics | 8-K: Current report
Jasper Therapeutics | 8-K: Current report
Jasper Therapeutics | 8-K: Current report
Jasper Therapeutics | 8-K: Current report
Jasper Therapeutics | 8-K: Current report
Jasper Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Jasper Therapeutics | 8-K: Jasper Therapeutics Reports Second Quarter 2023 Financial Results and Provides a Business Update
No Data